title: Simultaneous pancreas-kidney transplant compared with kidney transplant in Type I diabetic patients with end-stage renal disease.
authors.affiliation: Nephrology, Surgery and Urology Section, Reina Sofia Hospital, Córdoba, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Pérez
authors.forename: M D
authors.initials: MD
authors.lastname: Navarro
authors.forename: D
authors.initials: D
authors.lastname: del Castillo
authors.forename: R
authors.initials: R
authors.lastname: Santamaría
authors.forename: J
authors.initials: J
authors.lastname: Padillo
authors.forename: J C
authors.initials: JC
authors.lastname: Regueiro
authors.forename: P
authors.initials: P
authors.lastname: Aljama
mesh_terms: D000328:Adult; D000367:Age Factors; D002102:Cadaver; D003404:Creatinine / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000502:physiology; D006684:HLA-DR Antigens / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000601:surgery*; D016030:Kidney Transplantation / Q000009:adverse effects / Q000276:immunology; D007902:Length of Stay; D008297:Male; D016035:Pancreas Transplantation / Q000009:adverse effects / Q000276:immunology; D012086:Reoperation; D012189:Retrospective Studies; D014019:Tissue Donors; D016896:Treatment Outcome
chemical_list: D006684:HLA-DR Antigens; D007166:Immunosuppressive Agents; D003404:Creatinine